Robotic mitral valve repair using da Vinci Surgical System for mitral regurgitation: A safety and feasibility study

Robotic mitral valve repair using da Vinci Surgical System for mitral regurgitation: A safety and feasibility study - Robotic mitral valve repair: A safety and feasibility study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028160

Enrollment

Registered

2017-08-01

Start date

2017-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mitral regurgitation (MR)

Interventions

da Vinci will be rolled in after cardiopulmonary bypass and mitral valve plasy will be done with da Vinci. After mitral valve plasy is completed, da Vinci will be rolled out.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) MR is dianosed. 2) MR which is a operative indication (a) acute MR with symptum (b) chronic MR with NYHA II-IV and LVEF > 30% (c) chronic MR without symptum and LVEF ranging from 30% and 60% or LVDs > 40mm 3) obtained infromed consent 4) the age between 20 years and 80 years

Exclusion criteria

Exclusion criteria: 1) a patient who has a cancer 2) a patient with hemodialysis 3) a patient who participates in other clinical studies 4) a patient who had myocardial infarction within 30 days 5) a patient who had stroke within 180 days 6) a patient who had coronary stent within 30 days 7) a patient who has other procedures than mitral valve, except Maze or PV isolation 8) LVEF > 30% 9) BMI > 35kg/m2 10) active endocarditis 11) a patient who had previously sternotomy or right thoracotomy 12) a patient who had previously radiation therpay on his chest 13) a patient whom the principal investigator considers inappropriate for this clinical study

Design outcomes

Primary

Measure	Time frame
MR after 2 weeks postoperatively MR after 3 months postoperatively	—

Countries

Japan

Contacts

Public ContactYasushi Yoshikawa

Osaka University Hospital Cardiovascular Surgery

yoshikawa@surg1.med.osaka-u.ac.jp06-6879-3154

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026